A different study from 2021 by Pervaiz et al. [40] explored the therapeutic potential of CCR5 inhibition in colorectal cancer (CRC) with liver metastasis, using both siRNAs and the CCR5 antagonist maraviroc. This evidence concerns the gene CCR5 and colorectal cancer.